Haploidentical Lymphocytes With Nivolumab/Ara-C as Consolidation in Elderly AML Patients
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Cytarabine
Related studies linked through entity extraction aliases.
Study to Assess the Safety and Efficacy of Midostaurin (PKC412) in Combination With Standard Chemotherapy During Induction and Consolidation Followed by 12 Months of Maintenance Monotherapy in Patients With Newly-diagnosed FMS-like Tyrosine 3 (FLT3) Kinase Receptor-mutated Acute Myeloid Leukemia.
- Status
- COMPLETED
- Phase
- PHASE3
DLAAG in the Treatment of Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome With Blast Excess
- Status
- UNKNOWN
- Phase
- PHASE2
Pevonedistat With VXLD Chemotherapy for Adolescent/Young Adults With Relapsed/Refractory ALL or Lymphoblastic NHL
- Status
- COMPLETED
- Phase
- PHASE1
Pevonedistat, Cytarabine, and Idarubicin in Treating Patients With Acute Myeloid Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Study of Crenolanib With Fludarabine and Cytarabine in Pediatric Patients With Relapsed/Refractory FLT3-Mutated Acute Myeloid Leukemia
- Status
- WITHDRAWN
- Phase
- PHASE2
Cladribine in Combination With GAP in Patients With Refractory/Relapsed Acute Lymphoblastic Leukemia
- Status
- UNKNOWN
- Phase
- PHASE2
Onvansertib in Combination With Either Low-dose Cytarabine or Decitabine in Adult Patients With Acute Myeloid Leukemia (AML)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Ph I Study of Alvocidib and Cytarabine/Daunorubicin (7+3) in Patients With Newly Diagnosed Acute Myeloid Leukemia (AML).
- Status
- COMPLETED
- Phase
- PHASE1
ASIA Down Syndrome Acute Lymphoblastic Leukemia 2016
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Epigenetic Reprogramming in Relapse/Refractory AML
- Status
- COMPLETED
- Phase
- PHASE1
Blinatumomab, Methotrexate, Cytarabine, and Ponatinib in Treating Patients With Philadelphia Chromosome-Positive, or BCR-ABL Positive, or Relapsed/Refractory, Acute Lymphoblastic Leukemia
- Status
- RECRUITING
- Phase
- PHASE2
Nivolumab With Chemotherapy in Refractory MDS
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Study of Crenolanib vs Midostaurin Following Induction Chemotherapy and Consolidation Therapy in Newly Diagnosed FLT3 Mutated AML
- Status
- COMPLETED
- Phase
- PHASE3
Study Investigating the Efficacy of Crenolanib With Chemotherapy vs Chemotherapy Alone in R/R FLT3 Mutated AML
- Status
- COMPLETED
- Phase
- PHASE3
Geriatric Assessment & Genetic Profiling to Personalize Therapy in Older Adults With Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Venetoclax With Combination Chemotherapy in Treating Patients With Newly Diagnosed or Relapsed or Refractory Acute Myeloid Leukemia
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
iCare4: Genomic Signatures With Midostaurin in Acute Myeloid Leukemia (UF-HEM-004)
- Status
- WITHDRAWN
- Phase
- PHASE2
Treatment Protocol of the NHL-BFM and the NOPHO Study Groups for Mature Aggressive B-cell Lymphoma and Leukemia in Children and Adolescents
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Study of Venetoclax in Combination With Chemotherapy in Pediatric Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Leukemia of Ambiguous Lineage
- Status
- COMPLETED
- Phase
- PHASE1